Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Type
3.2. Snippet by Application
3.3. Snippet by Nature
3.4. Snippet by Manufacturing type
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rise in the geriatric population around the world
4.1.1.2. The launches of new drugs and approvals
4.1.2. Restraints
4.1.2.1. Drug price control policies across various countries
4.1.3. Opportunity
4.1.3.1. Rising demand for active pharmaceuticals ingredients
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. Russia Ukraine War Impact Analysis
8. Artificial Intelligence Impact Analysis
9. By Type
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.1.2. Market Attractiveness Index, By Type
9.2. Synthetic API *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Biotech API
10. By Application
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.1.2. Market Attractiveness Index, By Application
10.2. Cardiovascular*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Diabetes
10.4. Oncology
10.5. Orthopaedics
10.6. Neurology
10.7. NSAIDS
10.8. Others
11. By Nature
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
11.1.2. Market Attractiveness Index, By Nature
11.2. Generic API *
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Innovator API
12. By Manufacturing type
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Manufacturing type
12.1.2. Market Attractiveness Index, By Manufacturing type
12.2. Captive*
12.2.1. Introduction
12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
12.3. Merchant
13. By Region
13.1. Introduction
13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
13.1.2. Market Attractiveness Index, By Region
13.2. North America
13.2.1. Introduction
13.2.2. Key Region-Specific Dynamics
13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Manufacturing type
13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.2.7.1. U.S.
13.2.7.2. Canada
13.2.7.3. Mexico
13.3. Europe
13.3.1. Introduction
13.3.2. Key Region-Specific Dynamics
13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Manufacturing type
13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.3.7.1. Germany
13.3.7.2. U.K.
13.3.7.3. France
13.3.7.4. Spain
13.3.7.5. Italy
13.3.7.6. Rest of Europe
13.4. South America
13.4.1. Introduction
13.4.2. Key Region-Specific Dynamics
13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Manufacturing type
13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.4.7.1. Brazil
13.4.7.2. Argentina
13.4.7.3. Rest of South America
13.5. Asia-Pacific
13.5.1. Introduction
13.5.2. Key Region-Specific Dynamics
13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Manufacturing type
13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
13.5.7.1. China
13.5.7.2. India
13.5.7.3. Japan
13.5.7.4. Australia
13.5.7.5. Rest of Asia-Pacific
13.6. Middle East and Africa
13.6.1. Introduction
13.6.2. Key Region-Specific Dynamics
13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Manufacturing type
14. Competitive Landscape
14.1. Competitive Scenario
14.2. Market Positioning/Share Analysis
14.3. Mergers and Acquisitions Analysis
15. Company Profiles
15.1. Aurobindo Pharma*
15.1.1. Company Overview
15.1.2. Product Portfolio and Description
15.1.3. Financial Overview
15.1.4. Key Developments
15.2. Teva Pharmaceutical Industries Ltd
15.3. Pfizer Inc.
15.4. Novartis AG
15.5. BASF SE
15.6. Boehringer Ingelheim GmbH
15.7. Dr. Reddy’s Laboratories Ltd
15.8. Lupin Ltd
15.9. Mylan NV
15.10. Sun Pharmaceutical Industries Ltd.
LIST NOT EXHAUSTIVE
16. Appendix
16.1. About Us and Services
16.2. Contact Us